Startseite
Podcasts
All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier

All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier
All Things Urticaria is a podcast for healthcare professionals and anyone interested in learning more about urticaria. In earlier episodes, Prof. Marcus Maurer and colleagues explored the latest research and opinions on the pathogenesis and treatment of urticaria; Prof. Torsten Zuberbier has now taken over that role. The series offers in-depth expert discussions and is produced by UCARE, the Global Allergy and Asthma Excellence Network for Urticaria. The content is informational only and should not be taken as medical advice.
Folgen

Urticarial Vasculitis: Diagnosis and Treatment
In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Angelo Valerio Marzano from Milan about urticarial vasculitis and its challenging differential diagnoses. They explore how clinicians can distinguish urticarial vasculitis from chronic urticaria and other dermatological or systemic conditions and discuss practic

Urticaria as a Systemic Disease
In this episode of the Global Allergy and Asthma Excellence Network UCARE Podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Marta Ferrer from Spain about an important question: Is chronic spontaneous urticaria (CSU) only a skin disease, or is it a systemic inflammatory condition? Together, they discuss emerging evidence showing that urticaria affects far more than the skin and how th

Disease Modification in Urticaria
In this episode of the UCARE Global Allergy and Asthma Excellence Network (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Akio Tanaka from Hiroshima University, Japan, about an important question many patients ask: how long will chronic urticaria last, and can treatment influence the course of the disease? They discuss disease modifica

AI and the Future of Urticaria
In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Hermenio Lima discuss the growing role of artificial intelligence (AI) in medicine and how it may influence urticaria care, research, and patient management in the future. They discuss: 🔹 Can tools like ChatGPT help patients understand urticaria symptoms? 🔹 Why

Urticaria Triggers: Infection Insights
In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Maia Gotua discuss the role of infections in acute and chronic urticaria. They explore how infections can trigger, mimic, or worsen symptoms—and why careful clinical evaluation is key. They discuss: 🔹 How often do infections trigger acute urticaria, especially

A New Era in Urticaria Treatment
In this episode of “All Things Urticaria” — a podcast from UCARE, the Global Allergy and Asthma Excellence Network — Prof. Torsten Zuberbier and Prof. Ana Giménez-Arnau discuss the newly released international urticaria guidelines. Developed with contributions from more than 100 societies and hundreds of experts worldwide, these guidelines represent a major step forward in the management of chroni

Managing Urticaria in Resource-Limited Settings
In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Dr. Emma Kruger from Cape Town, South Africa, about managing urticaria in real-world clinical settings with varying access to therapies. Following the UCARE conference in Mumbai, they discuss global collaboration, treatment gaps, and practical approaches in resource-l

Drug Survival of Omalizumab
In this episode of the Urticaria podcast series, Prof. Torsten Zuberbier speaks with Reineke Soegiharto, PhD candidate and dermatology resident from UMC Utrecht, about the international UCARE study DRUSO-CU, which investigated the drug survival of omalizumab in chronic urticaria. They discuss: 🔹 What does “drug survival” mean and why is it a meaningful real-world outcome measure? 🔹 How long do pat

Visualizing Urticaria Worldwide
In this episode of the GA²LEN Urticaria Podcast, Professor Torsten Zuberbier is joined by Professor Simon Francis Thomsen from Denmark to introduce an exciting new global initiative within the UCARE network: WOW – Wheals and Angioedema of the World. The WOW project aims to create a worldwide, representative online image repository of urticaria and angioedema across all skin types, ethnicities, and

A New Era for Urticaria Treatment
In this short, conference-based episode, Professor Torsten Zuberbier, President of Global Allergy and Asthma Excellence Network, speaks with Professor Kiran Godse from Mumbai, India, directly from the UCARE Urticaria Conference, sharing the latest breakthroughs in urticaria research and treatment. The discuss: 🔹 What are the most important new developments in urticaria therapy? 🔹 How do BTK inhibi

Measuring What Matters: PROMs in Urticaria Care
In this episode of the GA²LEN (Global Allergy and Asthma Excellence Network) Podcast on Everything Urticaria, Professor Torsten Zuberbier talks with Dr. Karsten Weller, a leading expert and developer of patient-reported outcome measures (PROMs), about how these tools are transforming the management of urticaria and angioedema in both research and daily care. The discuss: 🔹 What are PROMs and why a

Why Do Hives Look the Way They Do?
In this episode of the GA²LEN (Global Allergy and Asthma Excellence Network) Podcast on Everything Urticaria, Professor Torsten Zuberbier speaks with Professor Michihiro Hide from Hiroshima, Japan — a pioneer in urticaria research — about an unexpected connection between dermatology and mathematics. The discuss: 🔹 Why do urticaria wheals form distinct shapes — round, annular, or geographic? 🔹 Wh

UDAY & New Guidelines: Empowering Patients Worldwide
In this episode, Prof. Torsten Zuberbier (Global Allergy and Asthma Excellence Network President) welcomes Prof. Petra Staubach, urticaria expert from Germany, to talk about Urticaria Day (UDAY) — held each year on October 1st — and why awareness is just as important as science. They discuss: 🔹 Why do we need a dedicated awareness day for urticaria? 🔹 What is the true burden of urticaria on patien

Living with SD: from Triggers to Future Therapies
In this episode, Sophia Neisinger welcomes Dr. Melba Muñoz, head of the Chronic Inducible Urticaria Program in Berlin, to discuss symptomatic dermographism (SD), the most common form of inducible urticaria. They discuss: 🔹 What exactly is symptomatic dermographism, and why is it so burdensome for patients? 🔹 How common is SD, and what did the latest international prevalence study reveal? 🔹 How can

Urticaria in Children: Diagnosis, Triggers & Treatment
In this episode, Prof. Torsten Zuberbier welcomes Dr. Larissa Brandão, pediatric allergist from the Federal University of São Paulo, Brazil, to talk about chronic urticaria in children — a condition that is often misunderstood and underdiagnosed. They discuss: 🔹 When does chronic urticaria typically begin in kids? 🔹 What role do infections or allergens, play? 🔹 Which treatments are available in pu

Itch & Urticaria: Mechanisms, Misconceptions & Hope
In this episode, Prof. Torsten Zuberbier welcomes Prof. Gil Yosipovitch, world-renowned itch researcher and dermatologist at the University of Miami, for an in-depth discussion on the science of itch in urticaria, and why histamine isn’t the full story. They discuss: 🔹 Why do antihistamines fail in up to 40% of urticaria patients? 🔹 What is MRGPRX2, and why is it such a promising target for future

Females, Pregnancy & Chronic Urticaria: What Doctors Should Know
In this episode, Dr. Sophia Neisinger welcomes Prof. Emek Kocatürk, leading urticaria researcher and UCARE expert from Istanbul, to explore the gender-specific aspects of chronic urticaria, with a special focus on pregnancy. They discuss: 🔹 Why do more women than men suffer from chronic urticaria? 🔹 How does pregnancy affect urticaria symptoms and treatment response? 🔹 What medications are safe du

The spectrum of cold urticaria
In this episode, Prof. Torsten Zuberbier calls up Dr. Hanna Bonnekoh, dermatologist and researcher at Charité Berlin, to dive into the complexities of cold-induced urticaria—particularly rare and familial forms that challenge current diagnostics and treatments. They discuss: 🔹 What makes wind-induced cold urticaria so difficult to diagnose? 🔹 How can physicians distinguish between histamine- and

Urticaria Tracking with CRUSE: A Game-Changer for Patients & Research
In this episode, Prof. Dr. Torsten Zuberbier (GA²LEN) welcomes Dr. Sophia Neisinger to discuss CRUSE, a digital health tool for chronic spontaneous urticaria (CSU). CRUSE is a free, globally available self-evaluation app that helps patients track their symptoms and provides valuable research data to improve urticaria care. They discuss: 📊 How CRUSE helps patients track their CSU symptoms daily.

Decoding Urticaria: Mast Cells, Triggers & Immune cell crosstalk
In this episode, Prof. Torsten Zuberbier (Charité Berlin, GA²LEN) welcomes Dr. Stefan Frischbutter, senior researcher at the Institute of Allergy in Berlin, to explore the fascinating world of mast cells and urticaria. They discuss: 🔬 The critical role of mast cells in immune responses and skin conditions like urticaria. 💡 How temperature, autoantibodies, and nerves can trigger mast cell activatio

Episode 104 – Insights from the Global Urticaria Forum (GUF)
CSU expert Professor Ana Maria Giménez-Arnau joins Professor Torsten Zuberbier to discuss the past, present, and future of treatment for CSU, exploring the current treatment paradigm and new approaches on the horizon that might bring us closer to disease-modifying therapies.Disclosure statement: AGA is or recently was a speaker and/or advisor for and/or has received research funding from Almirall,

Episode 103 - Solar urticaria
What steps can be taken to manage solar urticaria? Professor Torsten Zuberbier and Dr Lea Kiefer examine solar urticaria, discussing the role of skin type, management strategies, and treatment methods.Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.Feedback form ATU: https://forms.office.com/e/m6a2uEdsUH

Episode 102 - Understanding urticaria: What you need to know
Professor Torsten Zuberbier welcomes Dr Luis Ensina to discuss essential information for people with urticaria, highlighting the benefits of keeping a diary before medical appointments and how using patient-reported outcome tools can help doctors understand their condition better.Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and e

Episode 101 - Live from Global Urticaria Forum
Episode 101 – What were the highlights at Global Urticaria Forum (GUF) 2024? Professor Torsten Zuberbier and Dr Sophia Neisinger share their live reflections on the 7th Global Allergy and Asthma Excellence Network GUF event, including personal highlights, tips for junior physicians to make meaningful contributions to meetings and details on GUF 2025.
Do you have suggestions for future episodes? Pl

Episode 100 - Urticaria Day 2024
Episode 100 – In this special episode, recorded on Urticaria Day (UDAY), Professor Torsten Zuberbier and Dr Carolina Vera welcome CSU patient advocate Kristen Willard, who shares her story of living with urticaria. With live audience participation, this episode also delves into the cause of itch, the impact of urticaria on mental health, and novel treatments.
Do you have suggestions for future epi

Episode 99 - How should I treat patients who experience a slow or partial response?
Professors Torsten Zuberbier and Dave Khan share their experiences and approaches to treating people with refractory CSU, noting the importance of ensuring a correct diagnosis and following guideline recommendations.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Access additional resources by signing up

Episode 98 - Living with CSU: The patient outlook
“It stops my daily life as I know it.” Patient advocate with CSU Kristen Willard joins Professor Torsten Zuberbier to reflect on navigating life with CSU, including the impact on quality of life, potential triggers and the uncertainty around the disease.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Acce

Episode 97 - Clinical trials in urticaria: Part 2
This episode was recorded before 31 July 2024. Professor Marcus Maurer, Dr Carolina Vera Ayala, and Associate Professor Jonny Peter discuss how new therapeutics progress through the development pipeline, noting the “huge amount of data” required on safety before a molecule enters clinical trials. They also shed light on drug repurposing and why children are a “critical group” for inclusion in tria

Episode 96 - All things acute urticaria: Part 2
[This episode was recorded before 31 July 2024.] "Every chronic urticaria starts as acute urticaria, but not every acute urticaria becomes chronic." Associate Professor Dr Andaç Salman and Professor Marcus Maurer discuss causes of acute urticaria, how diagnosis and management can be improved, and UCARE’s research into drivers of “chronification”.
Do you have suggestions for future episodes? Please

Episode 95 - The similarities and differences between urticaria and mastocytosis
This episode was recorded before July 31, 2024. Professor Marcus Maurer and Dr Sigurd Broesby-Olsen discuss similarities and differences between urticaria and mastocytosis, two mast cell diseases. They then turn their attention to treatment, sharing their thoughts on ‘killing’ mast cells and the development of more targeted and less toxic therapies.
Do you have suggestions for future episodes? Ple

Episode 94 - The scientific approach to urticaria: Part 2
"We will only be able to cure this disease and treat it well if we know how it works." Back by popular demand, Dr Jörg Scheffel rejoins Professor Marcus Maurer to discuss the importance and intricacies of mast cell research in urticaria.”
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Additional resources

Episode 93 - The use of corticosteroids in urticaria
Dr Maryam Ali Al-Nesf joins Professor Marcus Maurer to discuss one of the big burdens of chronic urticaria: the "use, or should we say abuse, of cortisone" in chronic spontaneous urticaria.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Additional resources for this episode: Efficacy and safety of systemi

Episode 92 - Obesity and urticaria
Professor Christian Vestergaard and Professor Marcus Maurer discuss the link between obesity and urticaria, including how obesity contributes to chronic inflammation and the importance of P4 medicine (preventive, predictive, personalised, participatory) in urticaria treatment.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and exp

Episode 91 - EAACI 2024
Professor Marcus Maurer and Professor Martin Metz reflect on the European Academy of Allergy and Clinical Immunology (EAACI) congress 2024, including novel treatments on the horizon, key takeaways and expectations for future meetings.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Additional resources fo

Episode 90 - The scientific approach to urticaria
Professor Marcus Maurer welcomes Dr Jörg Scheffel to discuss urticaria, including techniques used to interrogate mast cells and examine interstitial fluid, and a technique used to identify autoimmune-mediated forms of urticaria.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Additional resources for this

Episode 89 - Is clinical remission in urticaria possible?
Professor Elias Toubi joins Professor Marcus Maurer to discuss remission in urticaria, including its definition and possible risk factors for long disease duration.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Additional resources for this episode: Clinical and laboratory parameters in predicting chroni

Episode 88 - Urticaria and sport
Associate Professor Elena Borzova joins Professor Marcus Maurer to discuss exercise as a trigger for urticaria in some athletes, including the paradoxical protective effect of exercise in people with urticaria.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Additional resources for this episode: Exercise-

Episode 87 - Clinical trials in urticaria
Professor Marcus Maurer welcomes Dr Carolina Vera Ayala and Associate Professor Jonny Peter to discuss participation in clinical trials for urticaria, including patient concerns around placebo treatment.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Additional resources for this episode: What is clinical

Episode 86 - CU: A Hong Kong perspective
Professor Marcus Maurer welcomes Professor Philip Li to discuss the management of urticaria in Hong Kong, including access to effective treatments and socioeconomic and cultural factors.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Additional resources for this episode: Hong Kong–Macau severe hives and

Episode 85 - How can we educate dermatologists on urticaria?
Dr Jason Hawkes joins Professor Marcus Maurer to discuss dermatologists’ lack of urticaria knowledge, including tips on encouraging the US dermatology community to use resources such as the CRUSE app.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Additional resources for this episode: Key messages: Urtic

Episode 84 - Does country make a difference?
“This is a global problem that requires global solutions, but I think they do come from what we learn in our settings.” Professor Marcus Maurer welcomes Dr Clive Grattan to discuss the differences in the treatment and management of urticaria across the UK and Germany, including guideline recommendations and new treatments on the horizon.
Do you have suggestions for future episodes? Please provide

Episode 83 - Chronic Angioedema Registry (CARE)
“I think CARE will grow and grow.” Dr Thomas Buttgereit joins Professor Marcus Maurer to discuss the recently launched Chronic Angioedema Registry (CARE), including benefits for patients, current capabilities and how to get involved.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following ext

Episode 82 - Managing autoimmune CSU
“There’s still so much we need to learn.” Dr João Marcelino joins Professor Marcus Maurer to discuss autoimmune chronic spontaneous urticaria, including indicative test results and hopes for the future.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links and access addition

Episode 81 - UCARE Conference 2023
“It’s really a catalyst to what the network does.” Professor Marcus Maurer asks Dr Luis Felipe Ensina to reflect on the UCARE Conference 2023, covering personal highlights and expectations for future meetings.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links and access a

Episode 80 - Living with CSU: The patient’s voice
“It doesn’t just affect one part of your life.” Arzoo Ahmed joins Professor Marcus Maurer to discuss the patient perspective, covering the reality and challenges of living with chronic spontaneous urticaria.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links and access add

Episode 79 - Apps, refugees, and the future of digital healthcare
“This is only the beginning of making use of this technology.” Professor Marcus Maurer is joined by asthma and allergic rhinitis expert Professor Jean Bousquet to discuss the collaboration that produced the MASK-Air and CRUSE apps, how they are helping Ukrainian refugees and the possibilities for future development.
Do you have suggestions for future episodes? Please provide feedback and offer you

Episode 78 - What is cold urticaria?
“Wouldn’t it be nice to find a cure?” Professor Marcus Maurer is joined by Dr Aurélie Du-Thanh to discuss cold urticaria, covering risk factors, diagnosis journey, and the most suitable treatment options.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links and access additi

Episode 77 - Antihistamines and urticaria
“We treat until it’s gone.” Professor Marcus Maurer is joined by Professor Gordon Sussman to discuss the use of antihistamines in people with urticaria, covering the history, side effects, safety and best practices.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links and ac

Episode 76 - Clinical nurse specialists: Leading collaborative care
Professor Marcus Maurer is joined by Clinical Nurse Specialist Lorena Lorenzo to discuss the responsibilities of the nurse’s role, and the potential benefits it brings for people living with urticaria.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links to access additional

Episode 75 - Urticaria in a veterinary setting
In response to listener requests, Professor Marcus Maurer is joined by veterinary specialist Professor Ralf Mueller to discuss how urticaria affects animals, including similarities and differences with the condition in humans and the challenges of treating performance animals.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expe

Episode 74 - Non-steroidal anti-inflammatory drugs in CSU
Professor Riccardo Asero joins Professor Marcus Maurer to offer advice on the use of non-steroidal anti-inflammatory drugs (NSAID) in people with chronic spontaneous urticaria (CSU). The experts discuss risk assessment and strategies to avoid respiratory and cutaneous hypersensitivity reactions in people who require these common medications to manage comorbidities.
Do you have suggestions for futu

Episode 73 - Urticaria and stress
Professor Marcus Maurer is joined by Professor Eduardo Souza Lima to explore the relationship between stress and urticaria, and the implications of mast cells and neuropeptides in chronic spontaneous urticaria.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links to access a

Episode 72 - IL-9, IL-10 and CSU pathogenesis
Dermatologist Professor Kiran Godse joins Professor Marcus Maurer to explore the use of JAK and STAT inhibitors in the management of chronic urticaria and how these drugs may impact quality of life for people with this condition.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following externa

Episode 71 - The patient perspective
Professor Marcus Maurer is joined by the president of Global Allergy & Airways Patient Platform (GAAPP), Tonya Winders, for a special Urticaria Day (UDAY) episode to discuss the role patient advocacy groups play in supporting individuals with chronic spontaneous urticaria. Both experts explore patient unmet needs and highlight methods clinicians can use to help overcome these barriers.
Do you

Episode 70 - Urticaria management in resource-poor settings
Dr Désirée Larenas-Linnemann and Professor Marcus Maurer delve into best practices for urticaria management in resource-poor settings, underlining the crucial role of accurate diagnosis and adherence to established guidelines. They also address trending topics in angioedema and urticaria treatment, such as antihistamine up-dosing and the complexities surrounding triple-combination therapies and th

Episode 69 - The burdens of angioedema
Professor Marcus Maurer is joined by Professor Paula Busse to explore the multifaceted burdens of angioedema for patients and physicians. They discuss issues surrounding timely diagnosis, interpreting ambiguous symptoms, patient concerns about medications, and enhancing quality of life monitoring.
Utilise the following external links to access additional resources relating to the topics discussed

Episode 68 - Angioedema and CSU
Dr Régis de Albuquerque Campos joins Professor Marcus Maurer to discuss the implications of angioedema and its impact on people living with chronic spontaneous urticaria (CSU). Dr Campos highlights diverse aspects of the burden of CSU and the impact misdiagnosis has on quality of life. Professor Maurer provides an overview of the current treatment landscape, differential diagnosis, unmet needs in

Episode 67 - Angioedema and artificial intelligence
Professor Markus Magerl joins Professor Marcus Maurer in this episode to explore the significance of differential diagnosis in the identification of angioedema in chronic spontaneous urticaria (CSU). Professor Magerl takes a deep dive into the prospective use of artificial intelligence (AI) in the analysis of data derived from a questionnaire utilising algorithmic models. Both professors, Maurer a

Episode 66 - Urticaria and the CRUSE app
Professor Marcus Maurer is joined by Dr Aistė Ramanauskaitė to explore the CRUSE app's potential advantages for individuals suffering from chronic spontaneous urticaria. Professor Maurer emphasises the importance and utilisation of the CRUSE app, while Dr. Ramanauskaitė delves into the various benefits and practical applications offered by the app.
Do you have suggestions for future episodes? Plea

Episode 65 - Audience proposed question: Guidance for potential treatments of CSU
Professor Martin Metz joins Professor Marcus Maurer to answer an audience proposed question focusing on what will guide physicians in the recommendations for individual patients to identify the most beneficial treatment option to treat chronic spontaneous and inducible urticaria. Both experts delve into the current treatment options available, and exciting treatments that are currently in clinical

Episode 64 - Urticaria: A general practitioner’s perspective
Professor Marcus Maurer is joined by GP Dr Dermot Ryan to discuss the role of GPs in the diagnosis and management of chronic urticaria. Professor Maurer and Dr Ryan highlight the positive impact that physicians have in limiting patient distress while increasing patient confidence, despite the time-limited interactions. They also explore the impact of mistreatment on a patient’s life.
Do you have s

Episode 63 - Soluble IgE receptor in urticaria
Professor Marcus Maurer asks Dr Sherezade Moñino-Romero about her research into soluble IgE receptor and its potential as a marker of treatment response in chronic urticaria. They also discuss the art of communicating science to the public and why it is so vital to do it effectively.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics a

Episode 62 - The role of angioedema in the treatment of CSU
Professor Marcus Maurer is accompanied by Professor Marc Riedl to delve into the symptomatology and pathophysiology of angioedema in chronic spontaneous urticaria (CSU). The mechanistic aetiology of angioedema within the context of CSU pathology is also explored. Professor Marc Riedl examines therapeutic treatments for patients concurrently experiencing angioedema in CSU while exploring how the ch

Episode 61 - Bruton’s tyrosine kinase inhibitors in the treatment of CSU
Professor Karla Arruda and Professor Marcus Maurer discuss the development and implementation of UCARE in Brazil, and its potential benefits for individuals suffering from chronic spontaneous urticaria (CSU). The conversation extends towards exploring the framework of the Brazilian UCARE centres and projects, and how it can be implemented in other countries. Professor Maurer delves into the clinic

Episode 60 - Updates from AAAAI Conference 2023
Professors Marcus Maurer and Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma & Immunology (AAAAI) conference held in San Antonio, Texas. In particular, Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussio

Episode 59 - Biomarkers in Chronic Urticaria
Dr. Murat Türk has joined Professor Marcus Maurer to discuss biomarkers in chronic spontaneous urticaria (CSU), focusing on immunoglobulin E (IgE) in particular. They emphasise the importance of using IgE testing appropriately in the treatment of CSU; as a prognostic parameter rather than a diagnostic technique. The discussion expands into a comparison between basophil testing and IgE testing and

Episode 58 - Symptomatic dermographism in Chronic Urticaria
Professor Marcus Maurer is joined by Dr Melba Munoz to take a deep dive into symptomatic dermographism. The discussion aims to explain the involvement of mast cells in CSU patients and attempts to answer some ongoing questions to help unravel the pathogenesis of dermographism in chronic urticaria.

Episode 57 - The importance of the Chronic Urticaria Registry (CURE)
Dr Pavel Kolkhir joins Professor Marcus Maurer to discuss the Chronic Urticaria Registry (CURE). The discussion includes explanations of the aims of CURE in collecting quality, real-life data on chronic urticaria patient characteristics, the course of disease, underlying causes, comorbidities, treatment responses, quality of life impairment and health care costs.

Episode 56 - Gut microbiome and CSU
Professor Marcus Maurer is joined by Dr Jie Li to discuss the role the gut microbiome plays in the disease progression of CSU. A particular focus is given to metabolism and homeostasis in patients with CSU, how the gut microbiome can impact CSU presentation, and the impact it can have on the efficacy of treatments such as antihistamines.

Episode 55 - Delayed pressure urticaria in the CSU landscape
Professor Alicja Kasperska-Zajac joins Professor Marcus Maurer to discuss a rare form of chronic inducible urticaria – delayed pressure urticaria. The discussion highlights the difficulties in undertaking differential diagnosis and the main differences when compared to chronic spontaneous urticaria, namely the absence of oedema and wheals.

Episode 54 - Mast Cell Involvement in Chronic Spontaneous Urticaria
Professor Yoshimichi Okayama joins Professor Marcus Maurer to discuss the role which mast cells play in the disease aetiology of chronic spontaneous urticaria. In particular, the discussion focuses on mast cell receptors and how they can be utilised in the diagnosis of CSU.

Episode 53 - Recurrent Angioedema in Chronic Spontaneous Urticaria
Professor Marcus Maurer is joined by Professor Asli Gelincik as they discuss recurrent angioedema in chronic spontaneous urticaria, and treatment options which are currently available to alleviate this pathology. The mechanistic actions of mast cell-mediated angioedema and bradykinin-mediated angioedema are discussed and their implications are analysed.

Episode 52 - Drug Survivability of Omalizumab in Chronic Urticaria
Dr Heike Röckmann, head of the drug survivability of omalizumab in chronic urticaria (DruSO-CU) project joins Professor Marcus Maurer to discuss the global project, the difficulties which were encountered, and how the UCARE network helped overcome these challenges. The focus of this podcast is on the importance of identifying the data in this important project.

Episode 51 - Chronic Spontaneous Urticaria: Never Give Up
In this episode, Professor Silvia Ferrucci joins Professor Marcus Maurer in discussing what the phrase ‘Never Give Up’ means to physicians treating urticaria, and for patients embarking on their treatment journey. Areas of special focus are given to guideline treatment algorithms and the implementation of the CRUSE app and Chronic Urticaria Registry (CURE) as tools to shift the balance of treating

Episode 50 - The development of treating urticaria over the last 2 decades
Professor Marcus Maurer is joined by Professor Luis Felipe Ensina where they discuss the founding days of urticaria treatment, and how urticaria clinics became available. Professor Maurer and Professor Ensina discussed how the treatment landscape, diagnostic techniques and further developments in the advancement of how clinicians treat patients with urticaria have evolved over the last two decades

Episode 49 - Psycho-neurodermatology in chronic urticaria and mental health
Professor Anna Zalewska-Janowska joins Professor Maurer to delve into fascinating area of psycho-neurodermatology and how this can impact the lives of individuals with urticaria. Prof. Zalewska-Janowska highlights the importance of how urticaria is linked to neurogenic inflammation in chronic urticaria.

Episode 48 - Patient advocacy and seeing through the patient’s eyes
In this episode Professor Marcus Maurer is joined by patient and patient advocate Elaine, who experiences chronic urticaria. She highlights the importance of connecting patients with each other, and discusses the opportunities that arise when patients work together with healthcare professionals.

Episode 47 - Chronic Urticaria and Systemic Auto-Inflammatory Syndromes
Dr Sinisa Savic joins Professor Dr Marcus Maurer in this podcast to discuss chronic urticarias and systemic auto-inflammatory syndromes, delving into differential diagnostic techniques and utilisation of genetics to determine causation of clinical presentations.

Episode 46 - Chronic Urticaria: A Chinese Perspective
During this episode, Professor Marcus Mauer is joined by Dr Zuotao Zhao of Beijing Medical University, China, to discuss the growing problem of chronic spontaneous urticaria within the Chinese population and delve into possible causes of such a high incidence.

Episode 45 - A Turkish Perspective
Professor Marcus Mauer is joined by Dr Murat Türk and Dr Ragıp Ertaş of UCARE in Turkey to discuss advancements in the treatments of urticaria, with a special focus on the implementation of artificial intelligence and machine learning.
Empfohlen

Nicos Weg – German course A1 | Videos | DW Learn German

heiseshow

Wohnsinnig vernetzt

5 Minuten Märchen - Josephine die kleine Maus - kurze Hörspiele für kleine Abenteurer

Elefantenrunde

WDR 3 Meisterstücke

Klassik für Klugscheisser

Think in German

Zum Goldenen Bock - Zwei Freunde, viele Autos

Apokalypse & Filterkaffee - Presseklub mit Markus Feldenkirchen

Deutsche Podcasts

SWR Umweltnews